| QUIDELORTHO DL-,001 |
| USA |
| Gesundheit |
| US2197981051 / A3DNGX |
| QL1A (Frankfurt) / QDEL (NASDAQ) |
| FRA:QL1A, ETR:QL1A, QL1A:GR, NASDAQ:QDEL |
| - |
| https://www.quidelortho.c.. |
|
QuidelOrtho Corporation is a diagnostic healthcare company that develops, manufactures, and markets testing solutions used across the healthcare continuum. The company focuses on in vitro diagnostics, with products and platforms spanning immunoassay,..
>Volltext.. |
| 814.15 Mio. EUR |
| 3402.59 Mio. EUR |
| 2395.7 Mio. EUR |
| 379.2 Mio. EUR |
| -939.39 Mio. EUR |
| -13.81 EUR |
| 2755.64 Mio. EUR |
| 110.57 Mio. EUR |
| -51.25 Mio. EUR |
| 0.12 |
| 0.49% |
| -144.99% |
| - |
| - |
| - |
| - |
| QUIDELORTHO |
| 03.11.26 |
|
||||
|